Clinical Trial Update: Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial update on allogeneic bone marrow transplantation with less intensive therapy; the study was terminated with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Cancer
• Leukemia
• Lymphoma
• Multiple Myeloma
• Myelodysplastic Syndromes
• Plasma Cell Neoplasm

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Kidney Cancer, Leukemia | Phase 2 | Status: TERMINATED | Results posted: 2020-05-12